Rakovina Therapeutics to Present ATR Inhibitor Data at Neuro-Oncology Meeting
The company says its poster will highlight AI-designed kt-5000AI compounds developed for PTEN-deficient brain tumours.
The company says its poster will highlight AI-designed kt-5000AI compounds developed for PTEN-deficient brain tumours.